RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-12.67%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.68B
AUM Growth
+$1.68B
(-10%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
8.2%
Top 10 Holdings %
Top 10 Hldgs %
55%
Holding
67
New
15
Increased
26
Reduced
11
Closed
7
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$55.3M |
| 2 |
BLU
BELLUS Health Inc.
BLU
|
$26.9M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$26.3M |
| 4 |
Insulet
PODD
|
$18.3M |
| 5 |
PTC Therapeutics
PTCT
|
$17.4M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$34.6M |
| 2 |
Illumina
ILMN
|
$30.2M |
| 3 |
Arrowhead Research
ARWR
|
$29.7M |
| 4 |
OrthoPediatrics
KIDS
|
$14.7M |
| 5 |
Myriad Genetics
MYGN
|
$10.5M |
Sector Composition
| 1 | Healthcare | 94.09% |
| 2 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arvinas
ARVN
$580M
| $17.4M | 1.04% |
809,623
+1,753
| +0.2% | +$37.8K |
|
27
Axsome Therapeutics
AXSM
$6.09B
| $17.1M | 1.02% |
846,121
+1,832
| +0.2% | +$37.1K |
|
28
Johnson & Johnson
JNJ
$429B
| $15.1M | 0.9% |
116,858
+22,946
| +24% | +$2.97M |
|
29
MiMedx Group
MDXG
$1.05B
| $14.5M | 0.86% |
+2,964,000
| New | +$14.5M |
|
30
Castle Biosciences
CSTL
$673M
| $13.5M | 0.8% |
+745,045
| New | +$13.5M |
|
|
DMTK
31
DELISTED
DermTech, Inc. Common Stock
DMTK
| $12.5M | 0.74% |
+2,386,871
| New | +$12.5M |
|
32
Transmedics
TMDX
$3.65B
| $12M | 0.71% |
503,266
-3,741
| -0.7% | -$88.9K |
|
33
QuidelOrtho
QDEL
$1.87B
| $10.8M | 0.64% |
+176,495
| New | +$10.8M |
|
34
Regenxbio
RGNX
$498M
| $10.4M | 0.62% |
291,168
-76,872
| -21% | -$2.74M |
|
|
QTNT
35
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $9.95M | 0.59% |
32,029
-6,572
| -17% | -$2.04M |
|
36
Standard BioTools
LAB
$493M
| $9.77M | 0.58% |
2,109,500
+32,029
| +2% | +$148K |
|
37
Natera
NTRA
$23B
| $9.43M | 0.56% |
+287,470
| New | +$9.43M |
|
38
Protagonist Therapeutics
PTGX
$3.62B
| $9.16M | 0.54% |
+762,283
| New | +$9.16M |
|
|
ODT
39
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $8.85M | 0.53% |
339,892
+736
| +0.2% | +$19.2K |
|
40
Arbutus Biopharma
ABUS
$753M
| $8.48M | 0.5% |
5,562,967
+29,874
| +0.5% | +$45.6K |
|
|
SILK
41
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $7.96M | 0.47% |
244,716
+20,994
| +9% | +$683K |
|
42
Exagen
XGN
$213M
| $7.93M | 0.47% |
+511,633
| New | +$7.93M |
|
|
PRNB
43
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $7.65M | 0.46% |
270,948
| – | – |
|
|
BWAY
44
Brainsway
BWAY
$296M
| $7.6M | 0.45% |
834,687
+237,471
| +40% | +$2.16M |
|
45
CytomX Therapeutics
CTMX
$350M
| $7.31M | 0.43% |
990,463
+2,144
| +0.2% | +$15.8K |
|
|
CHAC.U
46
DELISTED
Chardan Healthcare Acquisition Corp.
CHAC.U
| $7.18M | 0.43% |
600,000
| – | – |
|
47
uniQure
QURE
$954M
| $5.7M | 0.34% |
144,909
+314
| +0.2% | +$12.4K |
|
48
InMode
INMD
$917M
| $5.38M | 0.32% |
+500,000
| New | +$5.38M |
|
|
VIRX
49
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $5M | 0.3% |
+198,459
| New | +$5M |
|
50
Personalis
PSNL
$430M
| $3.74M | 0.22% |
255,000
+30,000
| +13% | +$440K |
|